Uncategorized

Rapport ‘fully prepared’ to launch seizure drug solo, CEO says

Published

on

In a wide-ranging interview, Abe Ceesay detailed how Rapport built an investor syndicate and why the company is confident it can join the ranks of successful, commercial-stage brain drugmakers.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version